Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
about
Effect of oral antacids on disposition of intravenous enoxacinUse of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumoniaChemotherapeuticsInterspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugsIn vivo evaluation of NM441, a new thiazeto-quinoline derivative.Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeysAbsorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansPharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in ratsPharmacokinetics of quinolones: newer aspects.Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.Pharmacokinetics of a novel quinolone, AT-4140, in animals.Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS.
P2860
Q24681208-4B809421-F193-4703-A7E1-559EF725E23AQ28320245-8CD808EB-9186-4EAC-A05A-252E0C964877Q30047670-C3D63B19-E07A-43DB-A3DC-36219897A2BBQ34011214-EF37A330-5121-48D4-83C8-F9E8796957D4Q34567225-D9C5C989-F5E9-48F1-BA56-32E97FEEBA43Q35537723-30C07387-80CD-4DEF-833D-87B43B22478DQ35568734-444367E0-9647-47E2-9F7E-DDEF4EBC15D7Q35639658-CCE40148-FF61-4440-9BB2-C543EA9E9713Q35643969-B5671215-0B01-44ED-8294-AF822B59A79EQ35651641-A510E53F-1B1B-444F-88B6-F489491DF893Q35759011-43C8745F-B720-4ECD-B262-FBFD9267461AQ35893937-6C7275A3-40D1-4C6A-8A88-8036FC268139Q36757519-946AA8B7-684F-4A43-A106-D079A915169AQ37222580-ED3FDF3E-F066-4022-9257-D745F413129FQ39780456-C66331AD-231B-49C2-92E5-10634562668EQ39815188-5C548B20-5EA3-4C4A-A32A-041CE94B3654Q39833562-22F48A45-CCD8-4B68-92D1-021D0584E6A4Q39850865-091E4356-709B-4A15-9920-4643959D22CEQ42199003-2D938132-0EDC-4167-B256-59C85856517B
P2860
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@ast
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@en
type
label
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@ast
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@en
prefLabel
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@ast
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
@en
P2093
P2860
P356
10.1128/AAC.24.1.54
P407
P577
1983-07-01T00:00:00Z